At KACTUS, they offer a comprehensive range of high-quality recombinant HLA-G and LILR proteins, to support research and development in immunology and therapeutic applications.
KACTUS has developed a full portfolio of tag-free or small-tag cytokines with verified cellular-level bioactivity for various cell culture applications.
KACTUS has demonstrated via ELISA & SPR binding assays that their MHC-peptide complexes & loaded peptide-ready MHCs have good binding affinity to TCRs.